                         SEQUENCE LISTING

<110>  Indapta Therapeutics, Inc.
       DIPIERRO, Guy
       DOS SANTOS, Gary
 
<120>  SUBSETS OF HUMAN NATURAL KILLER CELLS WITH ENHANCED 
       ANTIBODY-DIRECTED IMMUNE RESPONSES

<130>  776032000340

<140> Not Yet Assigned    
<141> Concurrently Herewith

<150>  62/671,358
<151>  2018-05-14

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  1
atatttacag aatggcacag g                                                 21


<210>  2
<211>  20
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  2
gacttggtac ccaggttgaa                                                   20


<210>  3
<211>  32
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  3
atcagattcg atcctacttc tgcagggggc at                                     32


<210>  4
<211>  32
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  4
acgtgctgag cttgagtgat ggtgatgttc ac                                     32


<210>  5
<211>  24
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  5
cccaactcaa cttcccagtg tgat                                              24


<210>  6
<211>  30
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  6
gaaatctacc ttttcctcta atagggcaat                                        30


<210>  7
<211>  29
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  7
gaaatctacc ttttcctcta atagggcaa                                         29


<210>  8
<211>  28
<212>  DNA
<213>  artificial sequence

<220>
<223>  158V Primer

<400>  8
gaaatctacc ttttcctcta atagggca                                          28


<210>  9
<211>  238
<212>  PRT
<213>  artificial sequence

<220>
<223>  CD16 (F158)

<400>  9

Gly Met Arg Thr Glu Asp Leu Pro Lys Ala Val Val Phe Leu Glu Pro 
1               5                   10                  15      


Gln Trp Tyr Arg Val Leu Glu Lys Asp Ser Val Thr Leu Lys Cys Gln 
            20                  25                  30          


Gly Ala Tyr Ser Pro Glu Asp Asn Ser Thr Gln Trp Phe His Asn Glu 
        35                  40                  45              


Ser Leu Ile Ser Ser Gln Ala Ser Ser Tyr Phe Ile Asp Ala Ala Thr 
    50                  55                  60                  


Val Asp Asp Ser Gly Glu Tyr Arg Cys Gln Thr Asn Leu Ser Thr Leu 
65                  70                  75                  80  


Ser Asp Pro Val Gln Leu Glu Val His Ile Gly Trp Leu Leu Leu Gln 
                85                  90                  95      


Ala Pro Arg Trp Val Phe Lys Glu Glu Asp Pro Ile His Leu Arg Cys 
            100                 105                 110         


His Ser Trp Lys Asn Thr Ala Leu His Lys Val Thr Tyr Leu Gln Asn 
        115                 120                 125             


Gly Lys Gly Arg Lys Tyr Phe His His Asn Ser Asp Phe Tyr Ile Pro 
    130                 135                 140                 


Lys Ala Thr Leu Lys Asp Ser Gly Ser Tyr Phe Cys Arg Gly Leu Phe 
145                 150                 155                 160 


Gly Ser Lys Asn Val Ser Ser Glu Thr Val Asn Ile Thr Ile Thr Gln 
                165                 170                 175     


Gly Leu Ala Val Ser Thr Ile Ser Ser Phe Phe Pro Pro Gly Tyr Gln 
            180                 185                 190         


Val Ser Phe Cys Leu Val Met Val Leu Leu Phe Ala Val Asp Thr Gly 
        195                 200                 205             


Leu Tyr Phe Ser Val Lys Thr Asn Ile Arg Ser Ser Thr Arg Asp Trp 
    210                 215                 220                 


Lys Asp His Lys Phe Lys Trp Arg Lys Asp Pro Gln Asp Lys 
225                 230                 235             


<210>  10
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  Signal peptide

<400>  10

Met Trp Gln Leu Leu Leu Pro Thr Ala Leu Leu Leu Leu Val Ser Ala 
1               5                   10                  15      


<210>  11
<211>  238
<212>  PRT
<213>  artificial sequence

<220>
<223>  CD16 (158V+)

<400>  11

Gly Met Arg Thr Glu Asp Leu Pro Lys Ala Val Val Phe Leu Glu Pro 
1               5                   10                  15      


Gln Trp Tyr Arg Val Leu Glu Lys Asp Ser Val Thr Leu Lys Cys Gln 
            20                  25                  30          


Gly Ala Tyr Ser Pro Glu Asp Asn Ser Thr Gln Trp Phe His Asn Glu 
        35                  40                  45              


Ser Leu Ile Ser Ser Gln Ala Ser Ser Tyr Phe Ile Asp Ala Ala Thr 
    50                  55                  60                  


Val Asp Asp Ser Gly Glu Tyr Arg Cys Gln Thr Asn Leu Ser Thr Leu 
65                  70                  75                  80  


Ser Asp Pro Val Gln Leu Glu Val His Ile Gly Trp Leu Leu Leu Gln 
                85                  90                  95      


Ala Pro Arg Trp Val Phe Lys Glu Glu Asp Pro Ile His Leu Arg Cys 
            100                 105                 110         


His Ser Trp Lys Asn Thr Ala Leu His Lys Val Thr Tyr Leu Gln Asn 
        115                 120                 125             


Gly Lys Gly Arg Lys Tyr Phe His His Asn Ser Asp Phe Tyr Ile Pro 
    130                 135                 140                 


Lys Ala Thr Leu Lys Asp Ser Gly Ser Tyr Phe Cys Arg Gly Leu Val 
145                 150                 155                 160 


Gly Ser Lys Asn Val Ser Ser Glu Thr Val Asn Ile Thr Ile Thr Gln 
                165                 170                 175     


Gly Leu Ala Val Ser Thr Ile Ser Ser Phe Phe Pro Pro Gly Tyr Gln 
            180                 185                 190         


Val Ser Phe Cys Leu Val Met Val Leu Leu Phe Ala Val Asp Thr Gly 
        195                 200                 205             


Leu Tyr Phe Ser Val Lys Thr Asn Ile Arg Ser Ser Thr Arg Asp Trp 
    210                 215                 220                 


Lys Asp His Lys Phe Lys Trp Arg Lys Asp Pro Gln Asp Lys 
225                 230                 235             


<210>  12
<211>  86
<212>  PRT
<213>  artificial sequence

<220>
<223>  FcRgamma chain

<400>  12

Met Ile Pro Ala Val Val Leu Leu Leu Leu Leu Leu Val Glu Gln Ala 
1               5                   10                  15      


Ala Ala Leu Gly Glu Pro Gln Leu Cys Tyr Ile Leu Asp Ala Ile Leu 
            20                  25                  30          


Phe Leu Tyr Gly Ile Val Leu Thr Leu Leu Tyr Cys Arg Leu Lys Ile 
        35                  40                  45              


Gln Val Arg Lys Ala Ala Ile Thr Ser Tyr Glu Lys Ser Asp Gly Val 
    50                  55                  60                  


Tyr Thr Gly Leu Ser Thr Arg Asn Gln Glu Thr Tyr Glu Thr Leu Lys 
65                  70                  75                  80  


His Glu Lys Pro Pro Gln 
                85      


